What question did this study set out to answer?

The aim is to develop a microfluidic device capable of detecting multiple blood biomarkers for metabolic diseases.

A Metal–Organic Gel Actualized Microfluidic-Paper Analysis Device for Detecting Multiple Blood Biomarkers of Metabolic Diseases in Point-of-Care Testing

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial demonstrates a new device detecting multiple blood biomarkers in metabolic diseases, suggesting improved point-of-care testing.

The aim is to develop a microfluidic device capable of detecting multiple blood biomarkers for metabolic diseases.
Developed a metal-organic gel microfluidic paper analysis device (MOG-μPAD).
Enabled simultaneous detection of biomarkers like glucose, uric acid, xanthine, and creatinine.
Evaluated sensitivity, specificity, cost-effectiveness, and usability in point-of-care settings.
Demonstrated sensitivity for multiple biomarkers with effective quantification of ox-TMB.
Showed stability for storage and ease of use in point-of-care testing settings.
Offered a multiplex strategy to monitor the pathogenesis and progression of several metabolic disorders.

Kong et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Randomized trial demonstrates a new device detecting multiple blood biomarkers in metabolic diseases, suggesting improved point-of-care testing.